Gene-therapy stocks surge on Roche-Spark deal

Shares of gene-therapy companies surged on Monday morning, buoyed by the news of Roche Holding AG’s acquisition of Spark Therapeutics Inc.

Shares of gene-therapy company bluebird bio inc. BLUE, +15.38% rose 14%, while shares of Intella Therapeutics Inc. NTLA, +4.73% climbed 5%. UniQure N.V. QURE, +28.32% stock jumped 30%.

Shares of CRISPR Therapeutics AG CRSP, +22.78% , which announced fourth-quarter earnings on Monday morning that missed Wall Street expectations, rose 21%. Shares of Sangamo Therapeutics Inc. SGMO, +0.00% rose 0.5%.

The news that Roche RHHBY, -0.21% had acquired Spark ONCE, +120.01% for a 122% premium to Friday’s closing price had investors speculating the deal was a signal of yet more M&A activity in the space ahead.

>>> Original Source <<<